Related Experiment Video
Updated: May 9, 2026

Intranasal Administration of CNS Therapeutics to Awake Mice
Published on: April 8, 2013
Intranasal insulin reduces olfactory sensitivity in normosmic humans
Yvonne F Brünner1, Christian Benedict, Jessica Freiherr
1Diagnostic and Interventional Neuroradiology, Uniklinik RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany. ybruenner@ukaachen.de.
Intranasal insulin reduced the ability to detect a non-food odorant in humans, impacting olfactory sensitivity. This suggests brain insulin signaling influences the olfactory threshold.
Area of Science:
- Neuroscience
- Endocrinology
Background:
- The human brain, particularly the olfactory bulb, possesses high densities of insulin receptors.
- The olfactory bulb is crucial for odor processing and is the oldest part of the olfactory central nervous system.
Purpose of the Study:
- To investigate the hypothesis that enhanced brain insulin signaling modulates human olfactory processing.
- To examine the effects of intranasal insulin administration on olfactory threshold and discrimination.
Main Methods:
- A double-blind, placebo-controlled, within-subject design was employed.
- 17 participants received a single intranasal dose of either insulin (40 IU) or placebo.
- Olfactory abilities were assessed using threshold and discrimination tests; blood glucose, insulin, and cortisol levels were measured.
Main Results:
- Intranasal insulin significantly decreased sensitivity to the odorant n-butanol compared to placebo (-13%; P = .025).
- Olfactory discrimination ability remained unaffected (P = .841).
- Plasma glucose levels dropped slightly, but this was not correlated with changes in olfactory sensitivity.
Conclusions:
- Intranasal insulin impairs olfactory sensitivity to non-food odors but does not affect olfactory discrimination.
- Brain insulin signaling variations likely impact the olfactory threshold in humans.
- Further research is needed to explore insulin's effect on the perception of food-related odors.
More Related Videos
05:44Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery
Published on: November 14, 2018
15:04Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
Published on: May 20, 2016
Related Concept Videos
Olfactory Receptors: Location and Structure
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Olfaction
The olfactory receptors are embedded in the cilia of the...
Oral Hypoglycemic Agents: Glinides
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...